These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 15610247)

  • 1. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats.
    Sánchez-Lozada LG; Tapia E; Santamaría J; Avila-Casado C; Soto V; Nepomuceno T; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J
    Kidney Int; 2005 Jan; 67(1):237-47. PubMed ID: 15610247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamics of hyperuricemia.
    Sánchez-Lozada LG; Tapia E; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J
    Semin Nephrol; 2005 Jan; 25(1):19-24. PubMed ID: 15660330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for uric acid in the progression of renal disease.
    Kang DH; Nakagawa T; Feng L; Watanabe S; Han L; Mazzali M; Truong L; Harris R; Johnson RJ
    J Am Soc Nephrol; 2002 Dec; 13(12):2888-97. PubMed ID: 12444207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild hyperuricemia induces glomerular hypertension in normal rats.
    Sánchez-Lozada LG; Tapia E; Avila-Casado C; Soto V; Franco M; Santamaría J; Nakagawa T; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J
    Am J Physiol Renal Physiol; 2002 Nov; 283(5):F1105-10. PubMed ID: 12372787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acute and chronic L-arginine treatment in experimental hyperuricemia.
    Sánchez-Lozada LG; Tapia E; López-Molina R; Nepomuceno T; Soto V; Avila-Casado C; Nakagawa T; Johnson RJ; Herrera-Acosta J; Franco M
    Am J Physiol Renal Physiol; 2007 Apr; 292(4):F1238-44. PubMed ID: 17190912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular hemodynamic changes associated with arteriolar lesions and tubulointerstitial inflammation.
    Sánchez-Lozada LG; Tapia E; Johnson RJ; Rodríguez-Iturbe B; Herrera-Acosta J
    Kidney Int Suppl; 2003 Oct; (86):S9-14. PubMed ID: 12969121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia.
    Sánchez-Lozada LG; Tapia E; Soto V; Avila-Casado C; Franco M; Zhao L; Johnson RJ
    Nephrol Dial Transplant; 2008 Apr; 23(4):1179-85. PubMed ID: 18048425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of febuxostat on the progression of renal disease in 5/6 nephrectomy rats with and without hyperuricemia.
    Sánchez-Lozada LG; Tapia E; Soto V; Avila-Casado C; Franco M; Wessale JL; Zhao L; Johnson RJ
    Nephron Physiol; 2008; 108(4):p69-78. PubMed ID: 18434753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats.
    Sánchez-Lozada LG; Tapia E; Jiménez A; Bautista P; Cristóbal M; Nepomuceno T; Soto V; Avila-Casado C; Nakagawa T; Johnson RJ; Herrera-Acosta J; Franco M
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F423-9. PubMed ID: 16940562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.
    Mazzali M; Kanellis J; Han L; Feng L; Xia YY; Chen Q; Kang DH; Gordon KL; Watanabe S; Nakagawa T; Lan HY; Johnson RJ
    Am J Physiol Renal Physiol; 2002 Jun; 282(6):F991-7. PubMed ID: 11997315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil prevents arteriolopathy and renal injury in subtotal ablation despite persistent hypertension.
    Tapia E; Franco M; Sánchez-Lozada LG; Soto V; Avila-Casado C; Santamaría J; Quiroz Y; Rodríguez-Iturbe B; Herrera-Acosta J
    Kidney Int; 2003 Mar; 63(3):994-1002. PubMed ID: 12631080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.
    Sánchez-Lozada LG; Soto V; Tapia E; Avila-Casado C; Sautin YY; Nakagawa T; Franco M; Rodríguez-Iturbe B; Johnson RJ
    Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1134-41. PubMed ID: 18701632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal oxidative stress induced by long-term hyperuricemia alters mitochondrial function and maintains systemic hypertension.
    Cristóbal-García M; García-Arroyo FE; Tapia E; Osorio H; Arellano-Buendía AS; Madero M; Rodríguez-Iturbe B; Pedraza-Chaverrí J; Correa F; Zazueta C; Johnson RJ; Lozada LG
    Oxid Med Cell Longev; 2015; 2015():535686. PubMed ID: 25918583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperuricemia causes glomerular hypertrophy in the rat.
    Nakagawa T; Mazzali M; Kang DH; Kanellis J; Watanabe S; Sanchez-Lozada LG; Rodriguez-Iturbe B; Herrera-Acosta J; Johnson RJ
    Am J Nephrol; 2003; 23(1):2-7. PubMed ID: 12373074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cortical vasoconstriction contributes to development of salt-sensitive hypertension after angiotensin II exposure.
    Franco M; Tapia E; Santamaría J; Zafra I; García-Torres R; Gordon KL; Pons H; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J
    J Am Soc Nephrol; 2001 Nov; 12(11):2263-2271. PubMed ID: 11675402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic predisposition to hypertension and microvascular injury in the remnant kidney model.
    Bidani AK; Griffin KA; Plott W; Schwartz MM
    J Lab Clin Med; 1993 Sep; 122(3):284-91. PubMed ID: 8409704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil treatment prevents glomerular hypertension and hyperfiltration in rats with renal ablation.
    Tapia E; Sanchez-Lozada LG; Soto V; Manrique AM; Ortiz-Vega KM; Santamaría J; Medina-Campos ON; Cristóbal M; Avila-Casado C; Pedraza-Chaverri J; Rodríguez-Iturbe B; Franco M
    Kidney Blood Press Res; 2012; 35(4):273-80. PubMed ID: 22378379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperuricemia induces endothelial dysfunction.
    Khosla UM; Zharikov S; Finch JL; Nakagawa T; Roncal C; Mu W; Krotova K; Block ER; Prabhakar S; Johnson RJ
    Kidney Int; 2005 May; 67(5):1739-42. PubMed ID: 15840020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
    Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
    J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular epithelial cell function and pathology following extreme ablation of renal mass.
    Schwartz MM; Bidani AK; Lewis EJ
    Am J Pathol; 1987 Feb; 126(2):315-24. PubMed ID: 3826297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.